Regence Health Policy Center

Check out our recap of our #healthcare #affordability discussion with state lawmakers at @CSGWEST last week. Includes insights from @AHIPCoverage, @NASHPhealth, and WA State Representative Macri on which #policy solutions will help advance affordability. regencehpc.com/publications/a…

From alleviating #provider burnout to personalizing care, how will #AI transform #healthcare? Check out our recent publication, recapping @AHIPCoverage's Consumer Experience and Digital Health Forum in Nashville earlier this month. regencehpc.com/publications/a…

What were the strategies discussed to rein in #healthcare costs during Oregon’s Cost Growth Target Hearing last week? ➡️Check out our recap where we spotlight Oregon’s cost growth trends and reveal potential solutions to curb rising health care costs. regencehpc.com/publications/o…

Regence HPC was proud to sponsor #StateofReform Inland West '23! WA Reps. Riccelli and Schmick provided an overview of their #healthpolicy priorities. The day was full of exceptional discussions on #behavioralhealth workforce, rural #healthcareaffordability, and broadband access.

A new study from @BCBSAssociation reveals hospital outpatient departments (HOPDs) charging as much as 58% more for common #healthcare procedures than ambulatory centers and doctors’ offices, raising costs for consumers. Learn more here: bcbs.com/press-releases…

The HPC team joined policymakers and health care leaders at two key conferences this summer. Discover which solutions were discussed to advance #behavioralhealth access and curb rising health care costs. Check out our recap here: regencehpc.com/publications/s…

** Attention Oregonians** House Bill 2045 would allow providers to wriggle out of accountability measures – learn how this undermines Oregon’s Cost Growth Target Program and efforts to lower costs for patients. oregoncapitalchronicle.com/2023/06/21/pro…

Thank you @RepKevinHern & @RepAnnieKuster for introducing the FAIR Act, which will help ensure patients aren’t paying more for care provided in a hospital-owned doctor’s office, preventing gaming of the system and protecting Americans from higher costs. bcbsa.co/6011gb7d5

With #HealthCosts on the rise, states are looking for strategies to lower health system costs. Check out our tracker for the latest on 2023 #legislation. loom.ly/4yicL_Q #HealthCareCosts

Which policies will promote and advance #affordable health care? Check out @BCBSAssociation's 3 policy recommendations that will lower #healthcare costs by over $767 billion in the next 10 years for Americans.

Interchangeability insights: Hear what Cate Lockhart has to say on achieving greater #biosimilar adoption and re-watch our event addressing the future of biosimilars in #pharmaceuticals. regencehpc.com/publications/i…

With 55 blockbuster biologics expected to come off patent by the end of the decade, how critical will #biosimilars be to advance competition and improve #drugaffordability? See what Leigh Purvis and other experts have to say about biosimilars: regencehpc.com/publications/i…

“55-60% of [prescription drug costs] are these high-cost drugs.” Re-watch our virtual event to see how #biosimilars have the potential to drastically reduce drug spending. youtu.be/q_-t76Enf-Y

In our first virtual event, we brought four experts to the stage to address the importance of how biosimilars promote competition, reduce costs and advance a safe and clinically effective alternative to biologics. Learn more here: regencehpc.com/publications/i…

Today is your last day to register for our first event, Improving Drug Affordability: The Promise of Biosimilars! Join us as we host four experts to address the future of #healthcare affordability and the potential of biosimilars to reduce drug spending. eventbrite.com/e/improving-dr…

Which #policies must be advanced to support the growing popularity of hospital at home programs? Here's one way: nytimes.com/2022/11/19/hea…

How is Regence increasing access and improving affordability in #prescriptiondrugs? Our latest article uncovers the promise of biosimilars advancing affordability and how Regence is leading the industry in adoption and utilization. Learn more here: regencehpc.com/publications/r…

How can the U.S. advance the adoption of #biosimilars? We will bring four experts to the stage to discuss the rapid growth of biosimilars entering the market and what the U.S. can learn from Europe’s success with biosimilars to advance greater adoption. eventbrite.com/e/improving-dr…

White bagging and alternative drug acquisition programs are mere symptoms of unsustainable, high #prescriptiondrug costs. Why would some #providers aim to remove existing tools that advance affordable, prescription drugs? Learn more here: regencehpc.com/publications/w…

👏 Thanks to our own Eleanor Escafi and Dr. Jim Polo for sharing your expertise at this year's Oregon @StateofReform. They joined leaders from @NWPermanente, @CareOregon and @OHAOregon to discuss the future of care delivery, access and payment. news.regence.com/blog/2022-oreg…